Objective To investigate the clinical efficacy of herbal fomentation combined with 308nm excimer light in the treatment of vitiligo and the effects on T cell subsets and inflammatory cytokines.Methods A total of 98 patients with vitiligo treated in the Dermatology Department of Kaifeng People's Hospital from May 2018 to May 2020 were selected and divided into two groups with 49 patients in each group according to random number table method. The control group was treated with 308 nm excimer light therapy, and the observation group received herbal fomentation combined with 308 nm excimer light therapy. The leukoplakia area, CD4+, CD8+, CD4+/CD8+ levels, IL-17 were recorded before treatment, 3 months after treatment, and 6 months after treatment, and TNF-α, IFN-γ levels and occurrence of adverse reactions were assessed. Results After treatment the total effective rate of clinical curative effect was 97.96% in observation group and 91.84% in control group, and the difference was statistically significant(P<0.05).Also there were statistically significant differences in the interaction effects of CD4+, CD4+/CD8+, IL-17, TNF-α and IFN-γ of the two groups between different time points, between groups and between time points and groups (P<0.05). Before treatment, there was no significant difference in each index between the two groups (P>0.05).Three and six months after treatment, the increase degree of CD4+ and CD4+/CD8+ inobservation group was higher than that before treatment,and higher than that in control group, but the degrees of IL-17, TNF-α and IFN-γ in observation group was lower than those before treatment,and lower than those in control group, and all the differences were statistically significant (P<0.05). Conclusions Herbal fomentation combined with 308 nm excimer light in the treatment of vitiligo can effectively improve the clinical efficacy, reduce the occurrence of adverse reactions, effectively regulate the immune functionand improve the stability of the immune system. Thus it is worth clinical promotion. |